Skip to main content
Clinical Trials/NCT05419310
NCT05419310
Recruiting
Not Applicable

Evaluation the Effectiveness of Two Modes of Rehabilitation Treatment and Elastic Taping for the Functional and Motor Recovery of the Patient Suffering From Low Back Pain.

Campus Bio-Medico University1 site in 1 country120 target enrollmentMay 12, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Low Back Pain
Sponsor
Campus Bio-Medico University
Enrollment
120
Locations
1
Primary Endpoint
changes in the low back pain related anxiety and depression
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The objective of this study is to verify which is the most effective type of rehabilitation treatment (rehabilitation based on core strengthening vs pilates) in patients suffering from low back pain.

The secondary objective is to verify whether the use of Kinesio Tape (KT) associated with rehabilitation treatment can have greater effects in the motor and functional recovery of patients suffering from Low Back Pain than traditional rehabilitation.

Detailed Description

Patients will undergo an initial assessment with the Physical Medicine and Rehabilitation Unit Physicians, during which the participants will sign the informed consent. After that a first evaluation will be carried out (T-1) during which the subjects will be asked to perform 10 consecutive sit-to-stand tests and 10 consecutive front bending tests. During the sit-to-stand and front bending tests, the kinematics of the spine will be recorded using two MIMU - XSENS DOT. The following scales will also be administered: * Roland and Morris Disability Questionnaire * Numerical Rating Scales (NRS) 11-point scale to assess the average intensity of pain during the last week * The Short Form Health Survey 36 (SF-36) questionnaire to assess quality of life * The Modified Somatic Perception Questionnaire (MSPQ) to assess pain somatization * The Hospital Anxiety and Depression Scale (HADS) scale to assess anxiety and depression * The Pain Catastrophizing Scale (PSC) to assess the catastrophization of pain * The Pain Self-Efficacy Questionnaire (PSEQ) for multidimensional pain assessment * The Fear Avoidance Beliefs Questionnaire (FABQ) to assess pain avoidance beliefs Patients will be randomized in 2 groups (Group A and Group B). For both groups there will be 12 treatment sessions, 3 times a week. (4 weeks) At mid-treatment (after 2 weeks), at the end of treatment (T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5) the same assessments of the first visit will be repeated.

Registry
clinicaltrials.gov
Start Date
May 12, 2022
End Date
March 30, 2025
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Campus Bio-Medico University
Responsible Party
Principal Investigator
Principal Investigator

Marco Bravi

Physiotherapist

Campus Bio-Medico University

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • Signing of informed consent
  • Chronic low back pain defined as non-specific self-reported low back pain that persists daily for at least 3 months or at least half of the days in the last 6 months.

Exclusion Criteria

  • Specific cause of low back pain: disc herniation, spinal stenosis, cauda equina syndrome, infection, fracture, tumor.
  • Pregnant women
  • Neurological disorders and neurological signs (e.g. CNS disorders, weakness, paresthesia)
  • Respiratory disorders
  • Previous spinal surgery.
  • Pain in the lower limbs or lesions limiting their function
  • Taking pain medication

Outcomes

Primary Outcomes

changes in the low back pain related anxiety and depression

Time Frame: At mid-treatment (2 weeks), at the end of treatment (4 weeks -T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5)

changes from baseline of the low back pain related anxiety and depression will be assessed through the use of the Hospital Anxiety and Depression Scale (HADS)

changes in the low back pain related disability

Time Frame: At mid-treatment (2 weeks), at the end of treatment (4 weeks -T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5)

changes from baseline of the low back pain disability will be assessed through the use of the Roland and Morris Disability Questionnaire

changes in the low back pain intensity and perception

Time Frame: At mid-treatment (2 weeks), at the end of treatment (4 weeks -T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5)

changes from baseline of the intensity of low back pain will be assessed through the use of the Numerical Rating Scale (NRS), the Modified Somatic Perception Questionnaire (MSPQ), the Pain Catastrophizing Scale (PCS), the Pain Self-Efficacy Questionnaire (PSEQ) and the Fear Avoidance Beliefs Questionnaire (FABQ)

changes in the spine kinematics

Time Frame: At mid-treatment (2 weeks), at the end of treatment (4 weeks -T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5)

changes from baseline of the low back pain kinematic will be assessed through the use of two MIMU - XSENS DOT. Subjects will be asked to perform 10 consecutive sit-to-stand tests and 10 consecutive front bending tests. During the tests, the kinematics of the spine will be recorded.

Secondary Outcomes

  • changes in the low back pain related quality of life(At mid-treatment (2 weeks), at the end of treatment (4 weeks -T1), and in follow-ups following 1 month (T2), 3 months (T3), 6 months (T4) and 12 months (T5))

Study Sites (1)

Loading locations...

Similar Trials